1. Field of the Invention
The invention relates to a device for and method of accelerating, and thereby imparting velocity and momentum to a fluid, and particularly to the use of corona discharge technology to generate ions and electrical fields especially through the use of ions and electrical fields for the movement and control of fluids such as air.
2. Description of the Related Art
A number of patents (see, e.g., U.S. Pat. No. 4,210,847 by Shannon, et al. and U.S. Pat. No. 4,231,766 by Spurgin) describe ion generation using an electrode (termed the “corona electrode”), attracting and, therefore, accelerating the ions toward another electrode (termed the “collecting” and/or “attracting” electrode), thereby imparting momentum to the ions in a direction toward the attracting electrode. Collisions between the ions and the fluid, such as surrounding air molecules, transfer the momentum of the ions to the fluid inducing a corresponding movement of the fluid.
U.S. Pat. No. 4,789,801 of Lee, U.S. Pat. No. 5,667,564 of Weinberg, U.S. Pat. No. 6,176,977 of Taylor, et al., and U.S. Pat. No. 4,643,745 of Sakakibara, et al. also describe air movement devices that accelerate air using an electrostatic field. Air velocity achieved in these devices is very low and is not practical for commercial or industrial applications.
U.S. Pat. Nos. 3,699,387 and 3,751,715 of Edwards describe the use of multiple stages of Electrostatic Air Accelerators (EFA) placed in succession to enhance air flow. These devices use a conductive mesh as an attracting (collecting) electrode, the mesh separating neighboring corona electrodes. The mesh presents a significant air resistance and impairs air flow thereby preventing the EFA from attaining desirable higher flow rates.
Unfortunately, none of these devices are able to produce a commercially viable amount of the airflow. Providing multiple stages of conventional air movement devices cannot, in and of itself, provide a solution. For example, five serial stages of electrostatic fluid accelerators placed in succession deliver only a 17% greater airflow than one stage alone. See, for example, U.S. Pat. No. 4,231,766 of Spurgin.
Accordingly, a need exists for a practical electrostatic fluid accelerator capable of producing commercially useful flow rates.
The invention addresses several deficiencies in the prior art limitations on air flow and general inability to attain theoretical optimal performance. One of these deficiencies includes excessive size requirements for multi-stage EFA devices since several stages of EFA, placed in succession, require substantial length along an air duct (i.e., along air flow direction). This lengthy duct further presents greater resistance to air flow.
Still other problems arise when stages are placed close to each. Reduced spacing between stages may produce a “back corona” between an attractor electrode of one stage and a corona discharge electrode of an adjacent next stage that results in a reversed air flow. Moreover, due to the electrical capacitance between the neighboring stages, there is a parasitic current flow between neighboring stages. This current is caused by non-synchronous high voltage ripples or high voltage pulses between neighboring stages.
Still another problem develops using large or multiple stages so that each separate (or groups of) stage(s) is provided with its own high voltage power supply (HVPS). In this case, the high voltage required to create the corona discharge may lead to an unacceptable level of sparks being generated between the electrodes. When a spark is generated, the HVPS must completely shut down for some period of time required for deionization and spark quenching prior to resuming operation. As the number of electrodes increases, sparks are generated more frequently than with one set of electrodes. If one HVPS feeds several sets of electrodes (i.e., several stages) then it will be necessary to shut down more frequently to extinguish the increased number of sparks generated. That leads to an undesirable increase in power interruption for the system as a whole. To address this problem, it may be beneficial to feed each stage from its own dedicated HVPS. However, using separate. HVPS requires that consecutive stages be more widely spaced to avoid undesirable electrical interactions caused by stray capacitance between the electrodes of neighboring stages and to avoid production of a back corona.
The present invention represents an innovative solution to increase airflow by closely spacing EFA stages while minimizing or avoiding the introduction of undesired effects. The invention implements a combination of electrode geometry, mutual location and the electric voltage applied to the electrodes to provide enhanced performance.
According to an embodiment of the invention, a plurality of corona electrodes and collecting electrodes are positioned parallel to each other or extending between respective planes perpendicular to an airflow direction. All the electrodes of neighboring stages are parallel to each other, with all the electrodes of the same kind (i.e., corona discharge electrodes or collecting electrodes) placed in the same parallel planes that are orthogonal to the planes where electrodes of the same kind or electrodes edges are located. According to another feature, stages are closely spaced to avoid or minimize any corona discharge between the electrodes of neighboring stages. If the closest spacing between adjacent electrodes is “a”, the ratio of potential differences (V1−V2) between a voltage V1 applied to the first electrode and a voltage V2 applied to the closest second electrode, and the distance between the electrodes is a normalized distance “aN”, then aN=(V1−V2)/a. The normalized distance between the corona discharge wire of one stage to the closest part of the neighboring stage should exceed the corona onset voltage applied between these electrodes, which, in practice, means that it should be no less than 1.2 to 2.0 times of the normalized distance from the corona discharge to the corresponding associated (i.e., nearest) attracting electrode(s) in order to prevent creation of a back corona.
Finally, voltages applied to neighboring stages should be synchronized and syn-phased. That is, a.c. components of the voltages applied to the electrodes of neighboring stages should rise and fall simultaneously and have substantially the same waveform and magnitude and/or amplitude.
The present invention increases EFA electrode density (typically measured in stages-per-unit-length) and eliminates or significantly decreases stray currents between the electrodes. At the same time, the invention eliminates corona discharge between electrodes of neighboring stages (e.g., back corona). This is accomplished, in part, by powering neighboring EFA stages with substantially the same voltage waveform, i.e., the potentials on the neighboring electrodes have the same or very similar alternating components so as to eliminate or reduce any a.c. differential voltage between stages. Operating in such a synchronous manner between stages, electrical potential differences between neighboring electrodes of adjacent EFA components remains constant and any resultant stray current from one electrode to another is minimized or completely avoided. Synchronization may be implemented by different means, but most easily by powering neighboring EFA components with respective synchronous and syn-phased voltages from corresponding power supplies, or with power supplies synchronized to provide similar amplitude a.c. components of the respective applied voltages. This may be achieved with the same power supply connected to neighboring EFA components or with different, preferably matched power supplies that produce synchronous and syn-phased a.c. component of the applied voltage.
First EFA stage 116 is powered by power supply 102 and second EFA stage 117 is powered by power supply 103. Both EFA stages as well as both power supplies 102 and 103 may be of the same design to simplify synchronization, although different designs may be used as appropriate to accommodate alternative arrangements. Power supplies 102 and 103 are synchronized by the control circuitry 104 to provide synchronized power outputs. Control circuitry ensures that both power supplies 102 and 103 generate synchronized and syn-phased output voltages that are substantially equal such that the potential difference between the electrodes 107 and 109 is maintained substantially constant (e.g., has no or very small a.c. voltage component). (Note: While the term “synchronized” generally includes both frequency and phase coincidence between signals, the phase-alignment requirement is further emphasized by use of the term “syn-phase” requiring that the signals be in-phase with each other at the relevant locations, e.g., as applied to and as present at each stage.) Maintaining this potential difference constant (i.e., minimizing or eliminating any a.c. voltage component) limits or eliminates any capacitive current flow between electrodes 107 and 109 to an acceptable value, e.g., typically less than 1 mA and preferably less than 100 μA.
The reduction of parasitic capacitive current between electrodes of adjacent EPA stages can be seen with reference to the waveforms depicted in
Ic=C*[d(V1−V2)/dt].
It directly follows from this relationship that, if the voltage across any capacitance is held constant (i.e., has no a.c. component), no current flows the path. On the other hand, even small voltage changes may create large capacitive current flows if the voltage changes quickly (i.e., large d(V1−V2)/dt). In order to avoid excessive current flowing from the different electrodes of the neighboring EFA stages, voltages applied to the electrodes of these neighboring stages should be synchronized and syn-phased. For example, with reference to
The closest spacing of electrodes of adjacent EFA stages may be approximated as follows. Note that a typical EFA operates efficiently over a rather narrow voltage range. The voltage Vc applied between the corona discharge and collecting electrodes of the same stage should exceed the so called corona onset voltage Vonset for proper operation. That is, when voltage Vc is less than Vonset, no corona discharge occurs and no air movement is generated. At the same time Vc should not exceed the dielectric breakdown voltage Vb so as to avoid arcing. Depending on electrodes geometry and other conditions, Vb may be more than twice as much as Vonset. For typical electrode configurations, the Vb/Vonset ratio is about 1.4-1.8 such that any particular corona discharge electrode should not be situated at a distance from a neighboring collecting electrode where it may generate a “back corona.” Therefore, the normalized distance aNn between closest electrodes of neighboring stages should be at least 1.2 times greater than the normalized distance “aNc” between the corona discharge and the collecting electrodes of the same stage and preferably not more than 2 times greater than distance “aNc.” That is, electrodes of neighboring stages should be spaced so as to ensure that a voltage difference between the electrodes is less than the corona onset voltage between any electrodes of the neighboring stages.
If the above stated conditions are not satisfied, a necessary consequence is that neighboring stages must be further and more widely spaced from each other than otherwise. Such increased spacing between stages results in several conditions adversely affecting air movement. For example, increased spacing between neighboring stages leads to a longer duct and, consequently, to greater resistance to airflow. The overall size and weight of the EFA is also increased. With synchronized and syn-phased HVPSs, these negative aspects are avoided by allowing for reduced spacing between HFA stages without reducing efficiency or increasing spark generation.
Referring to
For the purposes of illustration, we assume that all voltages and components thereof (e.g., a.c. and d.c.) applied to the electrodes of neighboring stages 414 and 415 are equal. It is further assumed that high voltages are applied to the corona discharge electrodes 401 and 403 and that the collecting electrodes 402 and 404 are grounded, i.e., maintained at common ground potential relative to the high voltages applied to corona discharge electrodes 401 and 403. All electrodes are arranged in parallel vertical columns with corresponding electrodes of different stages horizontally aligned and vertically offset from the complementary electrode of its own stage in staggered columns. A normalized distance 410 between corona discharge electrodes 401 and the leading edges of the closest vertically adjacent collecting electrodes 402 is equal to aN1. Normalized distance aN2 (413) between corona electrodes 403 of the second stage and the trailing edges of collecting electrodes 402 of the first stage should be some distance aN2 greater that aN1, the actual distance depending of the specific voltage applied to the corona discharge electrodes. In any case, aN2 should be just greater than aN1, i.e., be within a range of 1 to 2 times distance aN1 and, more preferably, 1.1 to 1.65 times aN1 and even more preferably approximately 1.4 times aN1. In particular, as depicted in
In summary, embodiments of the invention incorporate architectures satisfying one or more of three conditions in various combinations:
1. Electrodes of the neighboring EFA stages are powered with substantially the same voltage waveform, i.e., the potentials on the neighboring electrodes should have substantially same alternating components. Those alternating components should be close or identical in both magnitude and phase.
2. Neighboring EFA stages should be closely spaced, spacing between neighboring stages limited and determined by that distance which is just sufficient to avoid or minimize any corona discharge between the electrodes of the neighboring stages.
3. Same type electrodes of neighboring stages should be located in the same plane that is orthogonal to the plane at which the electrodes (or electrodes leading edges) are located.
It should be noted and understood that all publications, patents and patent applications mentioned in this specification are indicative of the level of skill in the art to which the invention pertains. All publications, patents and patent applications are herein incorporated by reference to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety.
This application is a continuation of U.S. patent application Ser. No. 10/188,069 filed Jul. 3, 2002 now U.S. Pat. No. 6,727,657 and entitled Electrostatic Fluid Accelerator For And A Method Of Controlling Fluid Flow and is related to U.S. patent application Ser. No. 09/419,720 filed Oct. 14, 1999 and entitled Electrostatic Fluid Accelerator, now U.S. Pat. No. 6,504,308, U.S. patent application Ser. No. 10/175,947 filed Jun. 21, 2002 and entitled Method of and Apparatus for Electrostatic Fluid Acceleration Control of a Fluid Flow, now U.S. Pat. No. 6,664,741; U.S. patent application Ser. No. 10/187,983 filed Jul. 3, 2002 and entitled Spark Management Method And Device; U.S. patent application Ser. No. 10/188,069 filed Jul. 3, 2002 and entitled Electrostatic Fluid Accelerator For and a Method Of Controlling Fluid Flow; U.S. patent application Ser. No. 10/295,869 filed Nov. 18, 2002 and entitled Electrostatic Fluid Accelerator which is a continuation of U.S. provisional application Ser. No. 60/104,573, filed on Oct. 16, 1998; U.S. patent application Ser. No. 10/724,707 filed Dec. 2, 2003 and entitled Corona Discharge Electrode and Method of Operating Same; U.S. patent application Ser. No. 10/735,302 filed Dec. 15, 2003 and entitled Method of and Apparatus for Electrostatic Fluid Acceleration Control of a Fluid; and U.S. patent application Ser. No. 10/752,530 filed Jan. 8, 2004 and entitled Electrostatic Air Cleaning Device, all of which are incorporated herein in their entireties by reference.
Number | Name | Date | Kind |
---|---|---|---|
1934923 | Heinrich | Nov 1933 | A |
1959374 | Lissman | May 1934 | A |
2765975 | Lindenblad | Oct 1956 | A |
2950387 | Brubaker | Aug 1960 | A |
3026964 | Penney | Mar 1962 | A |
3071705 | Coleman et al. | Jan 1963 | A |
3198726 | Trikilis | Aug 1965 | A |
3443358 | Drenning et al. | May 1969 | A |
3740927 | Vincent | Jun 1973 | A |
3907520 | Huang et al. | Sep 1975 | A |
3918939 | Hardt | Nov 1975 | A |
3981695 | Fuchs | Sep 1976 | A |
3984215 | Zucker | Oct 1976 | A |
4086152 | Rich et al. | Apr 1978 | A |
4216000 | Kofoid | Aug 1980 | A |
RE30480 | Gelfand | Jan 1981 | E |
4315837 | Rourke et al. | Feb 1982 | A |
4376637 | Yang | Mar 1983 | A |
4401385 | Katayama et al. | Aug 1983 | A |
4481017 | Furlong | Nov 1984 | A |
4600411 | Santamaria | Jul 1986 | A |
4604112 | Ciliberti et al. | Aug 1986 | A |
4643745 | Sakakibara et al. | Feb 1987 | A |
4646196 | Reale | Feb 1987 | A |
4649703 | Dettling et al. | Mar 1987 | A |
4740862 | Halleck | Apr 1988 | A |
4741746 | Chao et al. | May 1988 | A |
4772998 | Guenther, Jr. et al. | Sep 1988 | A |
4775915 | Walgrove, III | Oct 1988 | A |
4783595 | Seidl | Nov 1988 | A |
4789801 | Lee | Dec 1988 | A |
4790861 | Watai et al. | Dec 1988 | A |
4808200 | Dallhammer et al. | Feb 1989 | A |
4838021 | Beattie | Jun 1989 | A |
4878149 | Stiehl et al. | Oct 1989 | A |
4936876 | Reyes | Jun 1990 | A |
4938786 | Tonomoto | Jul 1990 | A |
5037456 | Yu | Aug 1991 | A |
5059219 | Plaks et al. | Oct 1991 | A |
5087943 | Creveling | Feb 1992 | A |
5136461 | Zellweger | Aug 1992 | A |
5138513 | Weinstein | Aug 1992 | A |
5163983 | Lee | Nov 1992 | A |
5199257 | Colletta et al. | Apr 1993 | A |
5257073 | Gross et al. | Oct 1993 | A |
5269131 | Brophy | Dec 1993 | A |
5369953 | Brophy | Dec 1994 | A |
5423902 | Strutz et al. | Jun 1995 | A |
5508880 | Beyer | Apr 1996 | A |
5542967 | Ponizovsky et al. | Aug 1996 | A |
5642254 | Benwood et al. | Jun 1997 | A |
5707422 | Jacobsson et al. | Jan 1998 | A |
5847917 | Suzuki | Dec 1998 | A |
D411001 | Pinchuk | Jun 1999 | S |
5920474 | Johnson et al. | Jul 1999 | A |
5942026 | Erlichman et al. | Aug 1999 | A |
D420438 | Pinchuk | Feb 2000 | S |
D427300 | Pinchuk | Jun 2000 | S |
6108504 | Dickhoff | Aug 2000 | A |
D433494 | Pinchuk et al. | Nov 2000 | S |
D434483 | Pinchuk | Nov 2000 | S |
D438513 | Pinchuk | Mar 2001 | S |
6195827 | Dumitriu | Mar 2001 | B1 |
D440290 | Pinchuk | Apr 2001 | S |
6224653 | Shvedchikov et al. | May 2001 | B1 |
6228330 | Herrmann et al. | May 2001 | B1 |
6394086 | Barnes et al. | May 2002 | B1 |
6574123 | Wiser et al. | Jun 2003 | B2 |
6888314 | Krichtafovitch et al. | May 2005 | B2 |
6919698 | Krichtafovitch | Jul 2005 | B2 |
7053565 | Krichtafovitch et al. | May 2006 | B2 |
20020122751 | Sinaiko et al. | Sep 2002 | A1 |
20020122752 | Taylor et al. | Sep 2002 | A1 |
20020127156 | Taylor | Sep 2002 | A1 |
20020155041 | McKinney, Jr. et al. | Oct 2002 | A1 |
20030033176 | Hancock | Feb 2003 | A1 |
20030147785 | Joannou | Aug 2003 | A1 |
20030165410 | Taylor | Sep 2003 | A1 |
20030170150 | Lau et al. | Sep 2003 | A1 |
20030206837 | Taylor et al. | Nov 2003 | A1 |
20030206839 | Taylor et al. | Nov 2003 | A1 |
20030206840 | Taylor et al. | Nov 2003 | A1 |
20030209420 | Taylor et al. | Nov 2003 | A1 |
20040025497 | Truce | Feb 2004 | A1 |
20040033340 | Lau et al. | Feb 2004 | A1 |
20040047775 | Lau et al. | Mar 2004 | A1 |
20040052700 | Kotlyar et al. | Mar 2004 | A1 |
20040057882 | Lau et al. | Mar 2004 | A1 |
20040079233 | Lau et al. | Apr 2004 | A1 |
20040212329 | Krichtafovitch et al. | Oct 2004 | A1 |
20040217720 | Krichtafovitch et al. | Nov 2004 | A1 |
20050151490 | Krichtafovitch | Jul 2005 | A1 |
Number | Date | Country |
---|---|---|
63-143954 | Jun 1988 | JP |
Number | Date | Country | |
---|---|---|---|
20040217720 A1 | Nov 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10188069 | Jul 2002 | US |
Child | 10806473 | US |